PACS executive granted 14,649 restricted stock units

PACS Group, Inc. Chief Human Resources Officer Trent Dean Bingham reported an equity compensation grant on Common Stock.

Rhea-AI Filing Summary

PACS Group, Inc. Chief Human Resources Officer Trent Dean Bingham reported an equity compensation grant on Common Stock. He acquired 14,649 restricted stock units (RSUs) for no cash payment, increasing his directly held equity-related position to 39,649 shares/units reported after the transaction.

The RSUs convert into one share of Common Stock each upon vesting. They are scheduled to vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, contingent on his continued service through each vesting date.

Insider Trade Summary

Grant/Award: 14,649 shares

Grant/Award 1 txn

Insider Bingham Trent Dean

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,649	$0.00	$0.00

Holdings After Transaction: Common Stock — 39,649 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PACS (PACS) report for Trent Dean Bingham?

PACS Group reported that Chief Human Resources Officer Trent Dean Bingham received a grant of 14,649 restricted stock units. These RSUs are a form of equity compensation and were reported as Common Stock-related holdings on his latest Form 4 filing.

How many PACS (PACS) shares or units does Trent Dean Bingham hold after this Form 4?

After the reported grant, Trent Dean Bingham holds 39,649 shares or units related to PACS Group Common Stock. This total reflects his direct ownership position following the 14,649 restricted stock units award disclosed in the Form 4.

What are the vesting terms of the PACS (PACS) restricted stock units granted to Bingham?

The 14,649 restricted stock units will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026. Vesting is conditioned on Trent Dean Bingham’s continued service with PACS Group through each applicable vesting date.

Did Trent Dean Bingham buy PACS (PACS) shares on the open market in this Form 4?

No, the filing shows a compensation-related acquisition coded as a grant, not an open-market purchase. Bingham received 14,649 restricted stock units for no cash consideration as part of his equity compensation package at PACS Group.

What does the Form 4 reveal about PACS (PACS) executive compensation structure?

The Form 4 indicates PACS Group uses restricted stock units as part of executive compensation. Trent Dean Bingham’s 14,649-unit grant, vesting over three years, aligns executive interests with shareholders by tying a portion of pay to future Common Stock value and continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/26/2026 - 06:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bingham Trent Dean

(Last) (First) (Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY UTAH 84101

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/24/2026		A		14,649(1)	A	$0	39,649	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)